VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors - PubMed (original) (raw)
. 2002 Apr 20;98(6):946-51.
doi: 10.1002/ijc.10283.
Affiliations
- PMID: 11948478
- DOI: 10.1002/ijc.10283
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors
Mirjami M-T Mattila et al. Int J Cancer. 2002.
Abstract
The spread of cancer cells to regional lymph nodes through the lymphatic system is the first step in the dissemination of breast cancer. In several human cancers including those of the breast and prostate, the expression of vascular endothelial growth factor C (VEGF-C) is associated with lymph node metastasis. Our study was undertaken to evaluate the effect of VEGF-C on metastasis of poorly invasive, estrogen dependent human MCF-7 breast cancer cells. MCF-7 breast cancer cells transfected with VEGF-C (MCF-7-VEGF-C) were grown as tumors in the mammary fat pads of nude mice implanted with subcutaneous estrogen pellets. Tumor lymphangiogenesis and lymph node metastasis were studied immunohistochemically using antibodies against lymphatic vessel hyaluronan receptor -1 (LYVE-1), VEGF receptor-3 (VEGFR-3), PECAM-1, pan-cytokeratin and estrogen dependent pS2 protein. Overexpression of VEGF-C in transfected MCF-7 cells stimulated in vivo tumor growth in xenotransplanted mice without affecting estrogen responsiveness. The resulting tumors metastasized to the regional lymph nodes in 75% (in 6 mice out of 8, Experiment I) and in 62% (in 5 mice out of 8, Experiment II) of mice bearing orthotopic tumors formed by MCF-7-VEGF-C cells whereas no metastases were observed in mice bearing tumors of control vector-transfected MCF-7 cells (MCF-7-Mock). The density of intratumoral and peritumoral lymphatic vessels was increased in tumors derived from MCF-7-VEGF-C cells but not MCF-7-Mock cells. Taken together, our results show that VEGF-C overexpression stimulates tumor lymphangiogenesis and induces normally poorly metastatic estrogen-dependent MCF-7 tumors to disseminate to local lymph nodes. These data suggest that VEGF-C has an important role in lymph node metastasis of breast cancer even at its hormone-dependent early stage.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
- Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. He Y, et al. J Natl Cancer Inst. 2002 Jun 5;94(11):819-25. doi: 10.1093/jnci/94.11.819. J Natl Cancer Inst. 2002. PMID: 12048269 - Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Skobe M, et al. Nat Med. 2001 Feb;7(2):192-8. doi: 10.1038/84643. Nat Med. 2001. PMID: 11175850 - Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, Harris AL, Bicknell R. Zhang HT, et al. J Natl Cancer Inst. 1995 Feb 1;87(3):213-9. doi: 10.1093/jnci/87.3.213. J Natl Cancer Inst. 1995. PMID: 7535859 - Molecular control of lymphatic metastasis.
Achen MG, Stacker SA. Achen MG, et al. Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review. - Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant.
Shibata MA, Ambati J, Shibata E, Yoshidome K, Harada-Shiba M. Shibata MA, et al. Med Mol Morphol. 2012 Dec;45(4):179-84. doi: 10.1007/s00795-012-0576-5. Epub 2012 Dec 7. Med Mol Morphol. 2012. PMID: 23224595 Review.
Cited by
- Role of CD44-Positive Extracellular Vesicles Derived from Highly Metastatic Mouse Mammary Carcinoma Cells in Pre-Metastatic Niche Formation.
Ikari A, Ito Y, Taniguchi K, Shibata MA, Kimura K, Iwamoto M, Lee SW. Ikari A, et al. Int J Mol Sci. 2024 Sep 9;25(17):9742. doi: 10.3390/ijms25179742. Int J Mol Sci. 2024. PMID: 39273689 Free PMC article. - Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors.
Bokhari SMZ, Hamar P. Bokhari SMZ, et al. Int J Mol Sci. 2023 Aug 28;24(17):13317. doi: 10.3390/ijms241713317. Int J Mol Sci. 2023. PMID: 37686121 Free PMC article. Review. - The ambivalent nature of the relationship between lymphatics and cancer.
Choi J, Choi E, Choi D. Choi J, et al. Front Cell Dev Biol. 2022 Sep 7;10:931335. doi: 10.3389/fcell.2022.931335. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36158182 Free PMC article. Review. - In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies.
Bekisz S, Baudin L, Buntinx F, Noël A, Geris L. Bekisz S, et al. Cancers (Basel). 2022 Mar 16;14(6):1525. doi: 10.3390/cancers14061525. Cancers (Basel). 2022. PMID: 35326676 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous